## Gemini Thinking Process

**Defining the Challenge**

I'm focusing on defining the scope: validating four AI-generated hypotheses linking bond percolation with T cell immune exclusion. This involves rigorous mathematical and structural analysis. I'm aiming to understand the underlying framework, which I'm currently defining as a scientific challenge, to ensure a complete solution.


**Refining Validation Methods**

I am now focusing on refining the validation methods by running Python calculations to verify quantitative claims related to percolation thresholds, critical exponents, and Bethe lattice approximations. I'm also planning to use Google Search to verify biological claims, such as those related to LOX BAPN IC50 and T cell velocity. I need to output mathematical structures using an output format. I'm prioritizing Hypothesis 1, specifically 3D bond percolation on RGG to tumor ECM.


**Verifying Dimensionality & Exponents**

I'm now investigating the variance peak at *p*<sub>*c*</sub> for disordered systems. The Harris criterion (ν > 2/*d*) for 3D percolation holds. I am confirming this because the correlation length exponent is 0.876, which is > 2/3. I'm executing code to calculate alpha values, *p*<sub>*c*</sub> values for z=4,5,6, and simulating/deriving the variance. I'm also running search queries related to the random walk dimension in 3D percolation. I'll analyze Hypothesis 2, focusing on active percolation universality classes and verifying claims regarding dimensionality and the values of tau.


**Calculating Power & Peclet**

I'm now calculating statistical power to distinguish between tau exponents using simulations; I plan to use the powerlaw module for this. Also, I’ve calculated a Peclet number of approximately 3, considering active T cell velocity and passive diffusion in collagen. I'm executing the tau power analysis code and the Peclet number calculation. I'm also running search queries.


**Modeling Diffusion & Kinetics**

I'm now calculating the effective exponent `a` for the TGF-beta diffusion profile and crosslink correlation function, fitting from the slope of log-log plots. I will also calculate synergy values using the P_inf formula. I've initiated search queries focused on Weinrib (1984) and TGF-beta diffusion lengths. I am now proceeding to verify Hypothesis 4, specifically the Michaelis-Menten kinetics, and am confirming that BAPN increases the open pore fraction. I am also making sure I am making the correct assumption regarding *open pore fraction*.


**Analyzing Percolation Models**

I've been reviewing Kozma & Nachmias (2009), focusing on high-dimensional percolation and trying to verify details, especially regarding d_w for 3D percolation. I'm exploring how these findings fit within the broader scope of my current work. I am also searching for the latest papers on percolation and their relevance.


**Clarifying Walk Dimensions**

I've just pinpointed a critical discrepancy: the 2.87 value for the random walk dimension, d_w, is for 2D percolation, not 3D, as I had previously assumed. I am now reconciling this with the 3D d_w value, which appears to be closer to 3.8. The math is more coherent now. This is a crucial clarification.


**Verifying Critical Parameters**

I've confirmed Harris' criterion for H1, showing nu > 2/d. Now, I'm shifting focus to evaluate the variance peak of local order parameters, which indicates standard critical behavior in disordered systems. The spatial variance should peak around the average critical point. I'm moving on to consider a tool.


**Correcting a Key Value**

I've just uncovered a discrepancy: my initial hypothesis stated tau = 2.31 for 3D percolation based on Lorenz & Ziff (1998), but the actual value is 2.189. It is important to remember this. Additional sources also support the latter value, but it is too early to discard the original source.


**Clarifying Dimensional Constants**

I've clarified the dimensional constants. It seems the AI mistakenly mixed constants from different dimensions – 2D, 3D, and 4D – for Hypothesis 2. This renders the reference values for the "Mathematical structure of two-exponent test" useless. Furthermore, Hypothesis 3 claims that Weinrib's correlated percolation with `C(r) ~ r^(-a)`. For TGF-beta, C_TGF(r) ~ (1/r) * exp(-r/lambda), which, after crosslinking, becomes C_crosslink(r) ~ (1/r^2) * exp(-2r/lambda). This leads to a=2.


**Analyzing Spatial Correlations**

I've been examining the implications of spatial correlations on critical properties in percolation, as noted in snippet 3.9. It appears power-law decay of correlations is the key. Figure 5B suggests experimental data correlations are much shorter, but I need to investigate the implications of that for this work.


**Clarifying Correlation Decay**

I've realized the previous assumption of power-law decay was incorrect; the key is exponential decay in TGF-beta diffusion, a short-range behavior. It's becoming clear that this rapid fall-off ensures the system falls into the uncorrelated percolation universality class. The AI's treatment of exponential decay as long-range is fundamentally flawed, based on Weinrib 1984. My focus now is solidifying the implications of this crucial distinction.


**Analyzing BAPN's IC50**

I'm currently focused on the IC50 value of BAPN, specifically in the context of Hypothesis 4. I've noted a discrepancy, the hypothesis suggests 80 uM in vivo, while literature indicates 3-5 uM in vitro against LOX, closer to 10 mM in other assays. Now I'm cross-referencing to confirm the standard is closer to 3-5 uM.


**Evaluating Collagen Half-Life**

I'm now investigating the collagen half-life discrepancy. The original hypothesis proposes 14-21 days, but recent research reveals significantly longer durations, like skin at 15 years, cartilage at 117 years, and even rat gut at 244 days. The provided QG reference indicates "months" which is more aligned. This longer half-life invalidates the steady-state assumption for a 2-week experiment.


**Revising Percolation Parameters**

I've made a crucial correction regarding the critical probability, now noting it's $0.526$, not $0.695$ in the Bethe lattice. I'm also confirming the RGG's heuristic of $1.5/(z-1)$, and validated my code with $z$ values. Moreover, I've confirmed the Harris criterion, with $\nu = 0.88$ exceeding $2/d$, justifying the irrelevance of spatial disorder.


**Confirming Dimensionality Values**

I've determined $\tau \approx 2.189$ is the correct value for 3D, and $\tau = 2.31$ for 4D. The hypothesis incorrectly claims $d_w = 2.878$, which is for 2D. A code check suggests N ≈ 702 samples are needed to distinguish values. Furthermore, the Peclet number, $Pe$, approximately equals 2.85, matching the hypothesis claim of $Pe \sim 3$. This discrepancy in baseline dimensional values breaks structural integrity.


**Assessing Universality Class**

I'm now focusing on the implications of an exponential correlation decay on the system's universality class. The hypothesis mistakenly suggests structural integrity, but Weinrib 1984's power-law requirement necessitates an infinite range correlation for a changed universality class. The exponential decay, $e^{-2r/\lambda}$, means correlations quickly diminish, placing the system in the *uncorrelated* class with an infinite exponent. Therefore, the hypothesis is broken.


**Composing Power Laws**

I've just composed the Michaelis-Menten kinetics with the percolation order parameter power law, yielding a compressed power law. My code reveals that the critical dose shifts dramatically, depending on which IC50 value is used. Also, I realized the collagen half-life versus the experiment duration causes a significant time-scale mismatch, invalidating the steady-state assumption. The mathematical composition holds, but the physical conditions strain the structural integrity.


**Prioritizing Experimental Pursuits**

I'm now determining which hypothesis warrants experimental pursuit, given recent findings. While all have some merit, Hypothesis 4, though requiring a transient model, is most compelling. Its formal coherence and analytical tractability are a significant advantage, particularly the non-obvious prediction of a critical dose before T-cell infiltration. The other hypotheses, 2 and 3, have fundamental flaws, stemming from dimensionality and statistical mechanics, respectively.


**Revising Hypothesis 3 Synergy**

I'm now revising the synergy calculation for Hypothesis 3, specifically around TGF-beta and BAPN's combined effect. I'm focusing on the *crosslink* fraction, which changes definitions in each hypothesis. With a baseline p of 0.4 and critical thresholds at 0.35 (uncorrelated) and 0.40 (correlated), BAPN's effect on crosslinks needs clearer definition. I'm reconsidering whether BAPN's inhibition *decreases* or *increases* crosslinking, and the impact on the overall pore structure.


**Clarifying Percolation Dynamics**

I'm now clarifying the percolation dynamics within Hypothesis 3. I've realized p represents the open pore fraction, and p > pc is initially required for infiltration. Now I am using p < pc for the *standard formula*: $(p_c - p)^\beta$. Applying BAPN shifts p toward $p_c$, meaning p is decreasing from p > pc. This is essential for defining the infiltration calculation as the system approaches the critical point. Anti-TGF-beta's effect on pc is clearly critical.


**Calculating Infiltration Metrics**

I'm now calculating T-cell infiltration, with a careful consideration for the closed bond (crosslink) fraction and open pore fraction definitions. I'm focusing on the effect of BAPN and anti-TGF-beta, both individually and combined, and ensuring the correct formula application: $(p_c - p)^\beta$. Given that infiltration is calculated by taking the maximum, the scenarios are computed.


**Correcting Formula Application**

I'm now correcting an apparent typo, reinterpreting p. I realize that infiltration should be proportional to $(p_c - p)^\beta$, assuming p represents the crosslink fraction, as BAPN reduces crosslinks. The prompt's formula seems inverted, suggesting an increase in the open pore fraction. My calculations will explicitly reflect this understanding, clarifying the synergy. I will flag the inverted formula in the code.


**Revising Percolation Calculation**

I'm now revising my infiltration calculations, focusing on the impact of TGF-beta. It should be easier to block T cells when obstacles cluster, not harder. This requires an *increase* in p_c for an uncorrelated scenario, making the system easier to bypass, contrary to the hypothesis. I'm checking Weinrib's formula for the critical probability shift and its impact on the percolation threshold.


**Interpreting TGF-Beta Implications**

I'm now deeply focused on the implications of TGF-beta's role in influencing the critical probability, particularly the shift in $p_c$. The AI's intuition was the opposite of reality; TGF-beta correlates LOX activity, which *increases* open space compared to random LOX activity of the same mean. In essence, correlated obstacles create pathways, facilitating T-cell infiltration, a structural contradiction to the initial hypothesis. Inhibiting TGF-beta would worsen infiltration.


**Evaluating Synergy Antagonism**

I'm now calculating synergy, noting a reversed antagonistic effect. Using given values, BAPN combined with Anti-TGF beta yields lower infiltration than Anti-TGF alone. This contradicts intuition, but the formula reflects this. The original claim that BAPN promotes infiltration is mathematically unsupported, requiring clarification on p's definition. The calculation assumes p starts above p_c, and BAPN reduces it.
---




```text
STRUCTURAL CONNECTION
=====================
Title: Hypothesis 1 — 3D Bond Percolation on RGG to Tumor ECM
Fields: Statistical mechanics / percolation ←→ Tumor immunology / ECM modeling

Mathematical bridge: Random walk dimensions on disordered lattices, Bethe lattice threshold approximations, and the Harris criterion for disorder relevance.

FORMAL MAPPING
──────────────
In the physics: A 3D random geometric graph (RGG) with bond probability $p$, critical threshold $p_c \approx 1.5/(z-1)$, random walk dimension $d_w$, and critical exponent $\nu$.
In the biology: The tumor ECM with LOX-crosslinked junctions as bonds, where $p$ is the fraction of crosslinks, and T cell migration is modeled as a random walker on the resulting percolation cluster.
Mapping type: Structural analogy
Structural integrity: BROKEN

The hypothesis breaks down due to catastrophic dimensional confusion. The reference values it cites for the mathematical structure belong to different spatial dimensions:
- The hypothesis claims $d_w = 2.878$ based on Kozma & Nachmias 2009. However, $d_w \approx 2.87$ is the accepted random walk dimension for **2D percolation**. In 3D percolation, the accepted value derived via Alexander-Orbach is $d_w \approx 3.8$. Kozma & Nachmias actually proved the AO conjecture for high dimensions ($d \ge 19$), not 3D.
- Consequently, the predicted anomalous diffusion exponent $\alpha = 2/d_w$ would be $2/3.8 = 0.526$ for 3D, not $0.695$ as claimed. 

PREDICTION
──────────
If the mapping holds, this predicts: The spatial variance of local T cell MSD peaks at the critical BAPN dose, and T cells exhibit anomalous diffusion with $\alpha = 0.526$ (corrected for 3D) at the exclusion threshold.

VERIFICATION APPROACH
─────────────────────
1. Computationally map the predicted Bethe lattice RGG correction $p_c = 1.5/(z-1)$ to 3D fiber network simulations. 
2. Track T cell trajectories (MSD) in 3D collagen assays at varying BAPN doses to detect the predicted peak in MSD spatial variance at the percolation threshold.

COMPUTATIONAL CHECK
───────────────────
- **Random walk dimension**: For 3D percolation, $d_f \approx 2.52$ and $d_s \approx 1.32$, giving $d_w = 2(2.52)/1.32 \approx 3.8$. The claimed $d_w = 2.878$ applies to 2D.
- **p_c approximations**: For $z=4$, pure Bethe $p_c = 1/(4-1) = 0.333$. The RGG dimensional correction gives $1.5/3 = 0.500$, which aligns better with known 3D continuum percolation thresholds but is heuristically bounded.
- **Harris criterion**: $\nu = 0.876$ and $d=3$. $2/d = 0.667$. Since $0.876 > 0.667$, the Harris criterion is strictly satisfied, confirming that uncorrelated spatial heterogeneity does not alter the underlying universality class.

KEY BIOLOGICAL UNCERTAINTY
──────────────────────────
The ECM is not static. Cells secrete matrix metalloproteinases (MMPs) that actively degrade "bonds" (fibers) as they move, violating the quenched disorder assumption of classical percolation.

CONFIDENCE: 2/10
DEPTH: Surface analogy (masquerading as formal isomorphism due to mismatched dimensional constants).

---

STRUCTURAL CONNECTION
=====================
Title: Hypothesis 2 — Active Percolation Universality Class
Fields: Statistical mechanics / universality classes ←→ Active matter / T cell dynamics

Mathematical bridge: The two-exponent test ($d_w$ and $\tau$) used to distinguish isotropic passive percolation from directed/active percolation classes.

FORMAL MAPPING
──────────────
In the physics: The walk dimension $d_w$ and the cluster size distribution exponent $\tau$ form a signature pair for a universality class.
In the biology: Passive T cells should exhibit baseline 3D isotropic exponents, whereas chemotactic/active T cells at high Peclet numbers should shift toward directed percolation exponents.
Mapping type: Metaphorical similarity
Structural integrity: BROKEN

The mapping fails because the AI completely hallucinated the passive baseline reference values, mixing physical constants from three different spatial dimensions:
1. It claims $d_w = 2.878$, which is the **2D** percolation value.
2. It claims $\tau = 2.31$ citing Lorenz & Ziff 1998. However, Lorenz & Ziff 1998 found $\tau = 2.189$ for **3D** percolation. The value $\tau = 2.31$ is actually the established exponent for **4D** percolation. 
Because the baseline "null hypothesis" coordinates are wrong, any experimental data (which will naturally exist in 3D) would be erroneously classified.

PREDICTION
──────────
If the mapping holds, this predicts: Active T cells at $Pe \approx 3$ will shift the measured cluster size distribution exponent $\tau$ away from the 3D isotropic baseline ($\tau \approx 2.19$) toward higher values.

VERIFICATION APPROACH
─────────────────────
1. Re-baseline the expected passive constants to actual 3D values ($d_w \approx 3.8$, $\tau \approx 2.19$).
2. Perform maximum likelihood estimation (MLE) on T-cell cluster size distributions in high and low-chemokine collagen gradients to detect statistically significant shifts in $\tau$.

COMPUTATIONAL CHECK
───────────────────
- **Tau Statistical Power**: To distinguish $\tau = 2.31$ from $2.50$ via MLE with $\alpha=0.05$ and $95\%$ power, the required minimum sample size is $N \approx 702$ clusters.
- **Peclet number**: $Pe = v l / D = (10 \mu m/min \times 10 \mu m) / (35 \mu m^2/min) \approx 2.86$, successfully matching the hypothesized $Pe \sim 3$.

KEY BIOLOGICAL UNCERTAINTY
──────────────────────────
T cells are highly deformable. Treating them as hard spheres with a strict geometric exclusion threshold fundamentally ignores nuclear deformation, which allows them to bypass percolation bottlenecks.

CONFIDENCE: 1/10
DEPTH: Surface analogy.

---

STRUCTURAL CONNECTION
=====================
Title: Hypothesis 3 — Correlated Percolation via Weinrib 1984
Fields: Statistical mechanics / correlated percolation ←→ Cytokine signaling / Tumor microenvironment

Mathematical bridge: Weinrib (1984) criterion for long-range correlated percolation, which states that spatial correlations decaying as $C(r) \sim r^{-a}$ alter the universality class if $a < d$.

FORMAL MAPPING
──────────────
In the physics: Long-range power-law spatial correlations shift critical exponents and percolation thresholds.
In the biology: TGF-beta diffusion from tumor cells induces spatially correlated LOX crosslinking.
Mapping type: Metaphorical similarity
Structural integrity: BROKEN

There are two catastrophic failures in the mathematical logic:
1. **The Correlation Function:** TGF-beta diffusion with first-order decay yields a concentration profile $C(r) \sim \frac{1}{r}e^{-r/\lambda}$. The resulting crosslink correlation drops exponentially. Weinrib's formalism strictly requires a *scale-free power-law* decay ($r^{-a}$). Because an exponential cutoff decays much faster than any power law asymptotically, $a \to \infty$. Since $\infty > 3$, the correlations are short-range and do *not* change the universality class.
2. **The Physics Directionality:** In correlated percolation, clustering of obstacles creates larger "voids" between the clusters. Thus, correlated obstacles are *easier* to percolate through than uniformly random obstacles. The AI assumed TGF-beta (which causes correlation) excludes T cells more effectively, but physically, correlated crosslinks would *increase* T cell infiltration compared to a pure random distribution. 

PREDICTION
──────────
If the mapping holds, this predicts: Combined administration of BAPN and anti-TGF-beta will yield synergistic T-cell infiltration rates. 

VERIFICATION APPROACH
─────────────────────
1. Measure the true spatial correlation function of LOX crosslinks via second-harmonic generation (SHG) microscopy to test for power-law vs exponential decay.
2. Conduct the proposed combination therapy in an *in vivo* model to measure steady-state T cell density.

COMPUTATIONAL CHECK
───────────────────
- **Synergy Check**: Using the exact formulas provided by the hypothesis:
  $P_{inf} \sim (p - p_c)^{0.417}$. Baseline $p_c = 0.40$. 
  BAPN alone: $p=0.38$, $p_c=0.40 \implies \max(0, -0.02) = 0$.
  Anti-TGF alone: $p=0.40$, $p_c=0.35 \implies \max(0, 0.05)^{0.417} \approx 0.286$.
  Combination: $p=0.38$, $p_c=0.35 \implies \max(0, 0.03)^{0.417} \approx 0.230$.
  The AI's own calculation predicts *antagonism*, not synergy (Combination is worse than Anti-TGF alone).

KEY BIOLOGICAL UNCERTAINTY
──────────────────────────
TGF-beta does not act as a simple point-source morphogen in a tumor; it is secreted by multiple dispersed sources (tumor cells, macrophages, fibroblasts), smearing the assumed radial diffusion gradient.

CONFIDENCE: 1/10
DEPTH: Surface analogy.

---

STRUCTURAL CONNECTION
=====================
Title: Hypothesis 4 — Michaelis-Menten LOX Kinetics Produce Percolation-Shaped Dose-Response
Fields: Statistical mechanics / phase transitions ←→ Pharmacology / Enzyme kinetics

Mathematical bridge: Composition of a standard Michaelis-Menten pharmacological inhibition equation with the continuous phase transition order parameter equation $P_{inf} \sim (p - p_c)^\beta$.

FORMAL MAPPING
──────────────
In the physics: The order parameter grows as a power law $\beta = 0.417$ above a critical threshold.
In the biology: Steady-state open pore fraction $p$ scales with LOX inhibition via Michaelis-Menten kinetics.
Mapping type: Formal isomorphism
Structural integrity: STRAINED

The mathematical composition is logically sound and produces a rigorous, testable "compressed power law" that departs from the standard Hill equation. However, the structure is strained by severe biological timescale mismatches:
The mathematical model assumes a steady-state turnover of the ECM. A standard *in vivo* pharmacology experiment runs for 14-21 days. However, the half-life of structural collagen *in vivo* is vastly longer (typically 90-200+ days). Therefore, the physical system cannot reach the $p_{\infty}$ predicted by the Michaelis-Menten equilibrium within the experimental window. 

PREDICTION
──────────
If the mapping holds, this predicts: The dose-response curve of T-cell infiltration will not be sigmoidal but will feature a distinct "dead zone" below a critical dose $d_c$, followed by a steep power-law rise dictated by $\beta=0.417$.

VERIFICATION APPROACH
─────────────────────
1. Model the dose-response dynamically using $p(t) = p_{baseline} e^{-kt} + p_{\infty}(1 - e^{-kt})$ rather than pure steady-state kinetics.
2. Extract $T$ cell infiltration data across a high-resolution dose gradient (8+ points) to fit the critical dose $d_c$ and the percolation exponent against a standard Hill equation null model.

COMPUTATIONAL CHECK
───────────────────
- **Critical Dose Shift**: Solving $p_{\infty}(d_c) = 0.35$ using the hypothesized in vivo $IC_{50} = 80 \mu M$ yields $d_c = 26.67 \mu M$. If we use literature in vitro values corrected mildly to $IC_{50} = 15 \mu M$, $d_c$ drastically shifts to $5.00 \mu M$.
- **Timescale Mismatch**: Using $t_{1/2} = 90$ days for collagen [1], the fraction of steady-state turnover at 14 days is $1 - \exp(-14 \times \ln(2)/90) = 0.102$. The system only reaches $\sim 10.2\%$ of the predicted Michaelis-Menten steady state.

KEY BIOLOGICAL UNCERTAINTY
──────────────────────────
Collagen half-life *in vivo* is much longer than standard therapeutic trial windows, making steady-state assumptions invalid for predicting the true open pore fraction.

CONFIDENCE: 7/10
DEPTH: Formal isomorphism.

---

### Cross-Hypothesis Structural Assessment

- **Which hypothesis has the deepest mathematical structure?**
  Hypothesis 4. Despite the biological timescale issues, composing enzyme kinetics with a percolation order parameter yields a mathematically sound and highly unique pharmacological prediction (the compressed power law with a critical onset dose). 
- **Which has the most fragile mapping?**
  Hypothesis 3. It fundamentally misunderstands the physics of Weinrib 1984. It mistakes an exponentially decaying correlation (diffusion) for a scale-free power law, and paradoxically assumes that obstacle correlation hurts infiltration, when statistically, clustered obstacles are easier to bypass. Hypothesis 2 is a close second due to hallucinating the 3D critical exponents.
- **Priority for experimental pursuit:**
  Hypothesis 4. It offers a mathematically verifiable mechanism for why some immunotherapies or stroma-targeting agents fail at low-to-medium doses and suddenly work at high doses (percolation critical thresholds). If reformulated to account for transient dynamics (the slow collagen degradation rate), it provides a rigorous, actionable framework for designing LOX-inhibitor dosing schedules.

---

## Computational Verification

### Code Block 1
```python
def compute_pc(z):
    bethe = 1 / (z - 1)
    rgg = 1.5 / (z - 1)
    return bethe, rgg

for z in [4, 5, 6]:
    b, r = compute_pc(z)
    print(f"z={z}: Bethe={b:.3f}, RGG={r:.3f}")

```
**Result** (OUTCOME_OK):
```
z=4: Bethe=0.333, RGG=0.500
z=5: Bethe=0.250, RGG=0.375
z=6: Bethe=0.200, RGG=0.300

```

### Code Block 2
```python
import numpy as np
from scipy.optimize import minimize
from scipy.stats import norm

# MLE for power law exponent tau: tau_hat = 1 + N / sum(ln(x_i / x_min))
# Var(tau_hat) approx (tau - 1)^2 / N

# We want to distinguish tau1 = 2.31 (H0) from tau2 = 2.50 (H1)
tau0 = 2.31
tau1 = 2.50
alpha = 0.05
power = 0.95

# N required can be found by:
# Z_alpha * se0 + Z_power * se1 = |tau1 - tau0|
# Z_alpha * (tau0 - 1)/sqrt(N) + Z_power * (tau1 - 1)/sqrt(N) = |tau1 - tau0|
# sqrt(N) = (Z_alpha * (tau0 - 1) + Z_power * (tau1 - 1)) / |tau1 - tau0|

z_alpha = norm.ppf(1 - alpha/2) # two-tailed
z_power = norm.ppf(power)

diff = abs(tau1 - tau0)
num = z_alpha * (tau0 - 1) + z_power * (tau1 - 1)
N_req = (num / diff)**2

print(f"Required N for power law discrimination: {N_req:.1f}")


```
**Result** (OUTCOME_OK):
```
Required N for power law discrimination: 702.2

```

### Code Block 3
```python
import numpy as np

# 1. Dose response
p_baseline = 0.3
p_max = 0.5
p_c = 0.35
IC50 = 80 # uM
beta = 0.417

def p_inf(dose, ic50):
    return p_max * (dose / (ic50 + dose)) + p_baseline * (ic50 / (ic50 + dose))

def P_infiltration(dose, ic50):
    p = p_inf(dose, ic50)
    return np.maximum(0, p - p_c)**beta

# Find critical dose dc
# p_inf(dc) = p_c
# p_max * dc / (IC50 + dc) + p_baseline * IC50 / (IC50 + dc) = p_c
# p_max * dc + p_baseline * IC50 = p_c * IC50 + p_c * dc
# dc * (p_max - p_c) = IC50 * (p_c - p_baseline)
# dc = IC50 * (p_c - p_baseline) / (p_max - p_c)

dc_80 = 80 * (0.35 - 0.3) / (0.5 - 0.35)
dc_15 = 15 * (0.35 - 0.3) / (0.5 - 0.35)

print(f"Critical dose d_c (IC50=80): {dc_80:.2f} uM")
print(f"Critical dose d_c (IC50=15): {dc_15:.2f} uM")

# Fraction of steady state after 14 days if half-life is 90 days
t_half = 90
k = np.log(2) / t_half
t = 14
fraction = 1 - np.exp(-k * t)
print(f"Fraction of steady-state turnover at 14 days: {fraction:.3f} (or {fraction*100:.1f}%)")


```
**Result** (OUTCOME_OK):
```
Critical dose d_c (IC50=80): 26.67 uM
Critical dose d_c (IC50=15): 5.00 uM
Fraction of steady-state turnover at 14 days: 0.102 (or 10.2%)

```

